Prevalence of Anemia and Immunological Markers in HIV-Infected Patients on Highly Active Antiretroviral Therapy in Northeastern Nigeria | Zendy

Ballah Akawu Denue | Zendy; Ibrahim Musa Kida | Zendy; Ahmed Hammagabdo | Zendy; Ayuba Dayar | Zendy; Mohammed Abubakar Sahabi | Zendy

Open Access

Prevalence of Anemia and Immunological Markers in HIV-Infected Patients on Highly Active Antiretroviral Therapy in Northeastern Nigeria

Author(s) -

Ballah Akawu Denue,

Ibrahim Musa Kida,

Ahmed Hammagabdo,

Ayuba Dayar,

Mohammed Abubakar Sahabi

Publication year - 2013

Publication title -

infectious diseases research and treatment

Language(s) - English

Resource type - Journals

ISSN - 1178-6337

DOI - 10.4137/idrt.s10477

Subject(s) - medicine , leukopenia , anemia , hematocrit , white blood cell , immunology , hemoglobin , viral load , incidence (geometry) , lymphocyte , gastroenterology , human immunodeficiency virus (hiv) , chemotherapy , physics , optics

There are conflicting reports on the impact of highly active antiretroviral therapy (HAART) in resolving hematological complications. Whereas some studies have reported improvements in hemoglobin and other hematological parameters resulting in reduction in morbidity and mortality of HIV patients, others have reported no improvement in hematocrit values of HAART-treated HIV patients compared with HAART-naïve patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research